Genfit plans to test its drug in second liver disease

NEW YORK (Reuters) - French drugmaker Genfit SA on Thursday said it would begin a midstage trial this year of its experimental drug elafibranor to treat primary biliary cholangitis, a chronic disease in which bile ducts in the liver are gradually destroyed.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro